Breaking news on gastrointestinal
Ultrasound First, Not CT, For Diagnosing Suspected Acute Appendicitis published
Fri, 09 May 2008 00:00:00 PDT
Color Doppler ultrasound, not CT, should be the first imaging examination for adult patients with suspected acute appendicitis, a new study emphasizes.The study of 420 medical records found that sonography correctly denied acute appendicitis in 303 of 312 adult patients, meaning it had a 97% specificity rate, said Diana Gaitini, MD, of Rambam Health Care Campus in Haifa, Israel.
Nitrates In Vegetables Protect Against Gastric Ulcers published
Thu, 08 May 2008 06:00:00 PDT
Fruits and vegetables that are rich in nitrates protect the stomach from damage. This takes place through conversion of nitrates into nitrites by the bacteria in the oral cavity and subsequent transformation into biologically active nitric oxide in the stomach. The Swedish researcher Joel Petersson has described the process, which also means that antibacterial mouthwashes can be harmful for the stomach.
Award Received By Boston Medical Center/Boston University School Of Medicine Researcher published
Thu, 08 May 2008 05:00:00 PDT
M. Michael Wolfe, M.D., professor of medicine and research professor of physiology and biophysics at Boston University School of Medicine and chief of the Gastroenterology Section at Boston Medical Center, was awarded an Individual Biomedical Research Award by The Hartwell Foundation.
New Data Show High Frequency Of Medical Claims For Gastrointestinal Events By Patients On Antiplatelet Therapy published
Wed, 07 May 2008 00:00:00 PDT
A review of medical claims from more than 70 managed care plans showed that 6.2 percent of patients prescribed the antiplatelet medicine clopidogrel submitted at least one insurance claim for ulcer or gastrointestinal bleeding, according to data released by Cogentus Pharmaceuticals, Inc. here at the annual meeting of the International Society for Pharmacoeconomics and Outcomes Research.
Anti-depressants May Benefit Some Patients With Irritable Bowel Disease published
Tue, 06 May 2008 01:00:00 PDT
Theories abound about the cause of Irritable Bowel Disease (IBD): Diet? Stress? Perhaps an infection? On the other hand, is it possible depression could be triggering the disease in some of the 20 per cent of Canadians suffering from this digestive system disorder? New research conducted by scientists in McMaster University's Intestinal Disease Research Program suggests it's highly likely that in some patients depression is wreaking havoc on the gut.
A Patient Who Was Diagnosed As IPN-B Without Hepatolithiasis? published
Sun, 04 May 2008 02:00:00 PDT
Intraductal papillary neoplasm of the bile duct (IPN-B) is a neoplastic lesion preceding invasive intrahepatic cholangiocarcinoma (ICC) and is a new definition of a tumor with papillary growth in the intra- or extra-hepatic bile duct. The authors reported a case of IPN-B with interesting histopathological findings and emphasized that cholangiography is especially helpful for the diagnosis of bile duct dilatation due to the infiltration of carcinoma cells.
Melanoma Of The Rectum: A Rare Entity published
Sat, 03 May 2008 10:00:00 PDT
Primary anorectal melanoma is a rare and very aggressive disorder. A report published in the World Journal of Gastroenterology addresses such a case. A 41-year-old man presented with a 6-month history of changed defecation and rectal bleeding. A 3-cm polypoid tumor of the lower rectum was found at rectosigmoidoscopy, which proved to be a leiomyosarcoma upon biopsy. Dissemination studies did not show any metastases. He underwent an APR.
The Double Life Of Proteins Discovered By Scientists published
Sat, 03 May 2008 03:00:00 PDT
Scientists at The Australian National University are a step closer to understanding the rare Hartnup disorder after discovering a surprising link between blood pressure regulation and nutrition that could also help to shed light on intestinal and kidney function.
Sorting Of CEA Modulated By Cholesterol, Implications For Inflammatory Bowel Disease published
Sat, 03 May 2008 02:00:00 PDT
In polarized Caco-2 cells, cholesterol was depleted by a combination of synthesis inhibition and plasma membrane extraction with complexing agents. This led to an increased sorting of CEA to the basolateral surface. Interestingly, polarity was not significantly affected by this approach. The association of CEA to lipid rafts, cholesterol, and sphingolipid-enriched microdomains was inhibited in parallel.This study, performed by a team led by Dr.
Early Treatment Of Stomach Infection May Prevent Cancer published
Sat, 03 May 2008 00:00:00 PDT
Based on research using a new mouse model of gastritis and stomach cancer, researchers from the Massachusetts Institute of Technology (MIT) say that prompt treatment of Helicobacter pylori (H. pylori) infections reverses damage to the lining of the stomach that can lead to cancer.
Active Ingredient In Florastor Probiotic Clinically Proven To Boost Efficacy Of Treatment For Clostridium Difficile-Associated Disease published
Thu, 01 May 2008 03:00:00 PDT
C. diff-associated disease (CDAD), otherwise known as severe intestinal disease brought on by the Clostridium difficile (C. diff) pathogen, has been the subject of heightened concern in the medical community. A new report released this month by the federal Agency for Healthcare Research and Quality revealed a 200 percent increase in potentially fatal diarrheal infections in U.S. hospitals between 2000 and 2005.
Gastric Juice For Diagnosis Of H. Pylori Infection In Patients On Proton Pump Inhibitors published
Thu, 01 May 2008 03:00:00 PDT
This study determined the efficiency of a gastric juice PCR test for the detection of H. pylori infection in patients receiving PPI therapy and compared it with histology and gastric biopsy PCR.This study, led by Dr Javed Yakoob, is described in a research article to be published in the March 14, 2008, issue of the World Journal of Gastroenterology.
Discovery Of High Rate Of Pediatric Complicated Idiopathic Gallstone Disease published
Thu, 01 May 2008 03:00:00 PDT
The prevalence of gallstones in adults of industrialized countries is approximately 10% and is showing a tendency to rise. Data for pediatric patients is scarce.A research article published on March 14, 2008, in the World Journal of Gastroenterology addresses this problem. The team lead by Dr.
Drug Target For The Most Potent Botulinum Neurotoxin Determined By Scientists published
Wed, 30 Apr 2008 03:00:00 PDT
Botulinum neurotoxin -- responsible for the deadly food poisoning disease botulism and for the beneficial effects of smoothing out facial wrinkles - can also be used as a dreaded biological weapon. When ingested or inhaled, less than a billionth of an ounce can cause muscle paralysis and eventual death.
Pregnancy And Extreme Nausea And Vomiting published
Mon, 28 Apr 2008 02:00:00 PDT
Mothers born in India and Sri Lanka are three times more likely to suffer from extreme nausea and vomiting in pregnancy (hyperemesis gravidarum) than ethnic Norwegians. This finding comes from Norwegian Institute of Public Health's study of 900,000 first-time pregnancies registered in the Medical Birth Registry of Norway over a forty year period.Earlier studies reported that 90 percent of pregnant women experience some degree of nausea and vomiting, whereas 0.
Progenics And Wyeth Announce FDA Has Approved Relistor published
Sun, 27 Apr 2008 00:00:00 PDT
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that the U.S. Food and Drug Administration (FDA) has approved RELISTOR™ (methylnaltrexone bromide) subcutaneous injection for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient.
FDA Approves Relistor For Opioid-Induced Constipation published
Fri, 25 Apr 2008 04:00:00 PDT
The U.S. Food and Drug Administration approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients with late-stage, advanced illness who are receiving opioids on a continuous basis to help alleviate their pain. Opioids are often prescribed on a continuous basis for patients with late-stage, advanced illness to help alleviate pain.
Goshen Center For Cancer Care Sponsors Symposium Dedicated To Increasing Awareness And Treatment Options For Inoperable Liver Cancer published
Fri, 25 Apr 2008 01:00:00 PDT
The world's leading liver cancer experts will come together May 2 and 3 during the fourth annual clinical symposium on liver-directed therapy at Chicago's Drake Hotel. Titled "Radiomicrosphere Therapy," the symposium is hosted by the Goshen Center for Cancer Care and led by Seza Gulec, M.D., F.A.C.S.
Identification Of Primary Driver Of Stomach Cancer Development published
Wed, 23 Apr 2008 03:00:00 PDT
In a discovery that could lead to the development of new treatments for gastric cancer, scientists at the Melbourne Branch of the international Ludwig Institute for Cancer Research (LICR) have discovered what appears to be the primary driver of tumor development in the stomach.
Early Diagnosis Vital In Oesophageal Cancer Detection published
Wed, 23 Apr 2008 00:00:00 PDT
People with oesophageal cancer are often enduring serious symptoms for over a year before seeking help according to a report launched by the Northern Ireland Cancer Registry at Queen's.The report, entitled Monitoring Care of Patients with Upper Gastrointestinal cancers: 2005, compares care for patients diagnosed with cancers of the oesophagus and stomach in 1996, 2001 and 2005.
Cisplatin Less Effective Than Standard Treatment For Patients With Anal Cancer published
Wed, 23 Apr 2008 00:00:00 PDT
When administered before chemoradiation, the common anti-cancer drug cisplatin neither improved disease-free survival nor reduced the number of colostomies needed when compared to the standard treatment for patients with anal canal cancer, according to a study published in the April 23 issue of the Journal of the American Medical Association.In the largest cooperative phase III randomized controlled trial of its kind, a multicenter research team led by Jaffer Ajani, M.D.
Interim Analysis Of Phase I/II Study Of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity In Metastatic Pancreatic Cancer published
Tue, 22 Apr 2008 00:00:00 PDT
Epeius Biotechnologies Corporation announced that Interim Analysis of an on-going Phase I/II study of Rexin-G for pancreatic cancer confirmed Rexin-G's anti-tumor activity with no major toxicity in patients with metastatic chemotherapy-resistant pancreatic cancer. The clinical trial design includes 5 escalating doses of intravenous Rexin-G ranging from 1 x 10e11 cfu twice a week to 4 x 10e11 cfu three times a week for 4 weeks.
FDA Approves Rotarix The First Vaccine Licensed To Complete The Rotavirus Immunisation Series By Four Months Of Age published
Mon, 21 Apr 2008 00:00:00 PDT
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has approved Rotarix® [Rotavirus Vaccine, live, oral] for the prevention of rotavirus gastroenteritis in infants. Rotarix will offer protection against the most commonly circulating rotavirus types in the U.S. and allow infants to complete the vaccination series by four months of age. The U.S.
NICE Launch Two Guides To Support Effective Commissioning Of Services: Faecal Incontinence And Cognitive Behavioural Therapy, UK published
Thu, 17 Apr 2008 03:00:00 PDT
The National Institute for Health and Clinical Excellence (NICE) has published a further two new commissioning guides to help the NHS in England effectively commission evidence-based care for patients.
Pitt Researchers Receive Funding In Support Of Gastrointestinal Cancer Research published
Thu, 17 Apr 2008 02:00:00 PDT
For the third year in a row, University of Pittsburgh Cancer Institute researchers have received funding from the GIST Cancer Institute - a patient driven organization that funds research on gastrointestinal stromal tumors, or GISTs. These tumors occur in the gastrointestinal tract and are particularly difficult to treat over time. The $135,000 award supports the research of Anette Duensing, M.D.
)
|
|
